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Background: Biopsy is a crucial step within the diagnostic cascade in patients with suspected bone or soft tissue
sarcoma. Open biopsy is still considered the gold standard. However, recent literature suggests similar results for
percutaneous biopsy techniques. Therefore, the aim of this retrospective analysis was to compare open and
percutaneous core needle biopsy (CNB) regarding their accuracy in diagnosis of malignant musculoskeletal lesions.
Methods: From January 2007 to December 2009, all patients with suspected malignant primary bone or soft tissue
tumour undergoing a percutaneous CNB or open biopsy and a subsequent tumour resection at our department
were identified and enrolled. Sensitivities, specificities, positive predictive values (PPV), negative predictive values
(NPV) and diagnostic accuracy were calculated for both biopsy techniques and compared using Fisher’s exact test.
Results: A total of 77 patients were identified and enrolled in this study. Sensitivity, specificity, PPV, NPV and
diagnostic accuracy were 100% for CNB in bone tumours. Sensitivity (95.5%), NPV (91.7%) and diagnostic accuracy
(93.3%) for open biopsy in bone tumours showed slightly inferior results without statistical significance (p > 0.05). In
soft tissue tumours favourable results were obtained in open biopsies compared to CNB with differences regarding
sensitivity (100% vs. 81.8%, p = 0.5), NPV (100% vs. 50%, p = 0.09) and diagnostic accuracy (100% vs. 84.6%, p = 0,19)
without statistical significance. The overall diagnostic accuracy was 92.9% for CNB and 98.0% for open biopsy
(p = 0.55). A specific diagnosis could be obtained in 84.2% and 93.9%, respectively (p = 0.34).
Conclusion: In our study we found moderately inferior results for the percutaneous biopsy technique compared to
open biopsy in soft tissue tumours whereas almost equal results were obtained for both biopsy techniques for
bone tumours. Thus, CNB is a safe, minimal invasive and cost-effective technique for diagnosing bony lesions. In
soft tissue masses, the indication for percutaneous core needle biopsy needs to be made carefully by an
experienced orthopaedic oncologist with respect to the suspected entity, size of necrosis and location of the lesion
to avoid incorrect or deficient results.
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Sarcomas of the bone account for only about 1% of all
tumour diseases [1]. Incidence rates of soft tissue sarco-
mas vary from 1.8 to 5.0 cases per 100,000 per year in
Germany [2]. According to the UK National Institute for
Health and Clinical Excellence (NICE) guidelines,
patients with suspected bone or soft tissue sarcoma have
to be transferred to dedicated centres for diagnostic
workup and integrated therapy. Regarding diagnosis, an
assessment consisting of clinical history and examin-
ation, imaging and tissue biopsy is recommended [3]. In
this context, biopsy in particular is a crucial step provi-
ding the basis for any further therapeutic strategy [4]. Bi-
opsy might be omitted only in the case of clinically and
radiologically unambiguous benign lesions [5].
The different procedures such as fine needle aspiration
(FNA), core needle biopsy (CNB) or open biopsy are all
associated with specific advantages and disadvantages
[6]. The objective of all these biopsy techniques is to
gain a representative tissue sample with minimal trauma,
considering the correct surgical approach for a later re-
section to facilitate limb-sparing procedures. Hereby, ac-
curate preoperative planning based on the diagnostic
findings is the crucial and most demanding part [5].
Open biopsy has for a long time been considered the
gold standard for the diagnosis of malignant and uncer-
tain tumours of the musculoskeletal system [4,5,7].
However, recent studies increasingly suggest similar
diagnostic accuracy for CNB due to improved histo-
pathological procedures [8,9]. Therefore, the aim of this
study was to analyse and compare the diagnostic accu-
racy of percutaneous CNB and open biopsy in suspected




All patients who underwent either a percutaneous or an
open biopsy, and received subsequent definite tumour re-
section in our musculoskeletal tumour centre between
January 2007 and December 2008 were enrolled. After-
wards, this patient sample was screened for primary bone
and soft tissue tumours based on the pathological report
from subsequent tumour resection. Exclusion criteria
were suspected benign lesions, excisional biopsy, second-
ary tumours and non-surgical treatment following biopsy.
Indication for either procedure was based on suspected
entity, radiological findings and location of the lesion.
Biopsy techniques
The approach for biopsy was always defined by an expert
orthopaedic tumour surgeon considering the subsequent
resection. The percutaneous biopsy was radiologically
guided either by sonography of soft-tissue masses or byCT of bone tumours, and was carried out using a 14-
gauge core needle. Three to five passes were taken to ob-
tain multiple samples throughout the tumour without
breaking the far wall. Additionally, a small cutaneous inci-
sion was performed to mark the biopsy canal for the fol-
lowing resection. The open biopsy was performed by an
expert orthopaedic tumour surgeon in line with the
planned resection and according to sarcoma principles
[5]. The samples were taken from the periphery of the
tumour due to the frequent presence of central necrosis.
The obtained tissue was stored on ice and immediately
transferred to our pathological institute for further ana-
lysis. All specimens were routinely stained with H & E.
Furthermore, histochemical and special immunohisto-
chemical stains were applied if appropriate.
Histology report
The review of the sections was performed by two senior
pathologists who specialised in the field of orthopaedic
oncology. All specimens were evaluated for the nature of
the lesion (benign or malignant) and the specific histo-
logical diagnosis.
Statistics
Histopathological results from biopsy and subsequent
tumour resection were compared. Sensitivity, specificity
positive predictive value (PPV), negative predictive value
(NPV) and diagnostic accuracy were calculated. Further
analysis was performed using SPSS software (IBM,
Armonk, NY, USA) and Fisher’s exact test with a 95%
confidence interval.
Results
In total, 77 patients underwent open biopsy (n = 31) or
percutaneous CNB (n = 46) in our study (Table 1). A
total sensitivity of 96.9% was determined for open biopsy
and 88.8% for CNB (P = 0.28). Specificity and the PPV
were 100% for both biopsy techniques. Differences in
favour of open biopsy were identified for NPV (94.1% vs.
83.3%, P = 0.55) and diagnostic accuracy (92.9% vs.
98.0%, P = 0.55). The correct histopathological diagnosis
compared to the subsequent resection specimen could
be obtained in 93.9% after open biopsy and in 84.2%
after percutaneous CNB. The difference was not statisti-
cally significant (P = 0.34) (Table 1).
Insufficient sampling occurred in CNB of one soft tis-
sue tumour (7.6%). During subsequent open biopsy, the
correct histopathological diagnosis could be obtained.
Furthermore, three biopsy specimens, one obtained by
open biopsy in a bone lesion and two by CNB in soft tis-
sue masses, were diagnosed as benign tumours but
revealed malignancy after final resection. The bone le-
sion was initially classified as an enchondroma but
turned out to be a low-grade chondrosarcoma in the
Table 1 Cumulative accuracy of open biopsy compared to
core needle biopsy (CNB) in bone and soft tissue tumours





Sensitivity 88.8% (P = 0.28) 96.9%
Specificity 100% 100%
Positive predictive value 100% 100%
Negative predictive value 83.3% (P = 0.55) 94.1%
Diagnostic accuracy 92.9% (P = 0.55) 98.0%
Specific diagnosis 84.2% (P = 0.34) 93.9%
P-values are shown for comparison between CNB and open biopsy (P < 0.05
was considered statistically significant).
Pohlig et al. European Journal of Medical Research 2012, 17:29 Page 3 of 5
http://www.eurjmedres.com/content/17/1/29resection specimen. Similarly, two lipomatous soft tissue
masses were diagnosed as lipoma whereas the subse-
quent resection disclosed a low-grade liposarcoma in
both cases. However, all tumours were resected accord-
ing to sarcoma principles. Thus, all three patients with
the incorrect diagnosis of a benign tumour were ade-
quately treated with a complete resection.
We observed impaired wound healing following one
open biopsy in our study. Significant complications, such
as haematoma or wound infection causing morbidity
that required intervention, or compromised the treat-
ment outcome, did not occur in the CNB or open biopsy
patient group.
Bone tumours
In total 48, patients with bone tumours were included
(Table 2). Open biopsy was performed in 15 and CNB in
33 patients, respectively. Sensitivity, specificity, PPV,
NPV and diagnostic accuracy were 100% for CNB.
Slightly inferior results were obtained with open biopsy
for sensitivity (95.5%), NPV (91.7%) and diagnostic ac-
curacy (93.3%), but the differences in values were not
statistically significant (P > 0.05) .
Soft tissue tumour
In 29 patients with soft tissue tumour, 16 open biopsies
and 13 CNBs were performed (Table 2). Here, open biopsy
revealed superior but not statistically significant results,Table 2 Accuracy of open biopsy compared to core needle bi








Positive predictive value 100% 100
Negative predictive value 50% 100
Diagnostic accuracy 84.6% 100for sensitivity (100% vs. 81.8%, P = 0.48), NPV (100% vs.
50%, P = 0.17) and diagnostic accuracy (100% vs. 84.6%,
P = 0.19) compared to CNB. Specificity and PPV were
100% for both biopsy techniques.
Discussion
In recent studies, diagnostic accuracy ranges from 74%
to 98% for CNB of bone and soft tissue tumours [8-13].
In line with these results, in our study we identified an
overall diagnostic accuracy of 92.9% in soft tissue
tumours and 98% in bony lesions, although many
authors also included metastatic tumours, usually yield-
ing higher accuracy than more heterogeneous sarcomas
[14,15]. However, Sung et al. found no significant differ-
ences regarding diagnostic accuracy between CNB of
heterogeneous and homogeneous bone tumours [16].
The correct histopathological diagnosis compared to the
resection specimen was obtained in 84.2% of soft tissue
masses and 93.9% of bony lesions in our study, confirm-
ing previously published results [8,9,17].
Comparing open biopsy and CNB in suspected malig-
nant bone tumours, we identified slightly superior
results for CNB. However, considering the relatively
small number of cases included in our series, the results
should presumably be almost equal in a larger patient
sample. CNB of soft tissue tumours revealed inferior
results compared to open biopsy in the current study.
These findings correlate well with recent literature, indi-
cating that very heterogeneous tumours including lipo-
sarcoma, angiosarcoma and synovial sarcoma are,
amongst others, potentially difficult to diagnose by CNB
[9,16,17]. In this context, Kasraeian et al. found signifi-
cantly deficient results regarding specific diagnosis in a
prospective study comparing open biopsy with CNB in
soft tissue tumours [18]. Favourable results were
obtained, and there was only one non-diagnostic sample
in our study (7.6%). However, this is presumably attribu-
ted to our relatively small patient sample.
To prevent lower diagnostic accuracy due to insufficient
or inadequate sampling in CNB, McCarthy proposed a full
discussion between orthopaedic surgeons, radiologists and
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ducted by a well-trained interventional radiologist or
orthopaedic surgeon [4,7,19,20]. Regardless of meeting ei-
ther recommendation, one CNB sample was insufficient
in our series emphasizing the importance of harvesting
tissue from multiple passes within the tumour.
A major disadvantage of CNB, apart from insufficient
sampling, is the fixation of the tissue in formalin, as
pathologic analysis is mostly limited to histology and
immunohistochemistry, and frozen samples are needed
for recent molecular diagnostic approaches such as real-
time PCR (rt-PCR) or microarray analysis [21,22]. Fur-
thermore, the acquisition of additional tissue for a cryo-
bank or research purposes is limited with CNB.
On the other hand, CNB is associated with less
morbidity and fewer complications compared to open
biopsy. In recent studies, complication rates for open bi-
opsy ranging from 0% to 17% are quoted [4,7,12,18,19].
Core needle biopsy, in contrast, has a reported compli-
cation rate of 0% to 7.4% [7,8,11,12,18,23,24]. Most
commonly, haematoma, bleeding and infection are men-
tioned [12,25,26]. In our series there was no significant
complication associated with either biopsy technique.
However, it has to be noted that all open biopsies
were performed according to the sarcoma principles
with intensive haemostasis and application of a redon
drain [5].
Overall, we identified good results for both biopsy
techniques. However, we have to note some limitations
of our study mainly due to the retrospective design.
First, we were not able to compare the pathological
grading of biopsy samples to the resection specimens,
because grading was not performed in every case
for two main reasons. One problem was possible false
negative results if a low-grade area within these very he-
terogeneous tumours was sampled. Furthermore, gra-
ding of tumour samples harvested after neoadjuvant
chemotherapy may be misleading and thus, is rarely
conducted. A subsequent grading for this study was not
possible in these cases. Second, we performed only one
kind of biopsy technique in each patient. The indication
for either procedure was made by a well-trained senior
orthopaedic surgeon based on the clinical and radio-
logical findings as well as his experience. Accordingly,
there is a possible bias in favour of core needle biopsy.
Third, we investigated a quite heterogeneous study
population in terms of tumour entities. Although we
only included patients with suspected sarcomas, great
differences remain regarding histopathological analysis.
Furthermore, the diagnostic standard by which both
techniques were judged was based on complete surgical
resection and the final clinical diagnosis of the ortho-
paedic oncologist. Although this is a good measure, a
possibly wrong diagnosis could influence our results.Conclusion
In our study, moderately inferior results were found for
the percutaneous biopsy technique compared to open
biopsy of soft tissue tumours, whereas almost equal
results were obtained in bone tumours. Thus, CNB is a
safe, minimally invasive and cost-effective technique for
diagnosis of bony lesions. In soft tissue masses, the indi-
cation for percutaneous CNB needs to be made carefully
by an experienced orthopaedic oncologist with respect
to suspected entity, extent of necrosis and location, to
avoid incorrect or deficient results.
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